IDEXX Laboratories, Inc. vs Tencent Music Entertainment Group - ADR — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Tencent Music Entertainment Group - ADR trades at $8.38 (market cap $12.83B). The key difference: IDEXX Laboratories, Inc. is far larger — about 3.2× Tencent Music Entertainment Group - ADR's market cap, and Tencent Music Entertainment Group - ADR pays a 3.02% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Tencent Music Entertainment Group - ADR for 67 Days on average.
| IDXX | TME | |
|---|---|---|
Market Cap | $40.43B | $12.83B |
Volume | 692,164 | 3,618,478 |
Sector | Health | Media |
52-Week High | $766.68 | $23.71 |
52-Week Low | $504.70 | $7.74 |
Typical Hold Time | 46 Days | 67 Days |
Enterprise Value | $41.32B | $10.77B |
Dividend Yield | — | 3.02% |
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
Tencent Music Entertainment (TME) trades at $8.38, up 4.88% today, but technical indicators signal a bearish trend with moving averages and ADX suggesting selling pressure. Fundamentally, the company shows strong profitability with 26.28% net margin and attractive valuation at 9.33 P/E ratio. Recent Q2 2026 earnings beat expectations with $0.25 EPS, though revenue growth remains modest. The company recently completed a $1 billion notes offering to strengthen its financial position.
TME presents a compelling value opportunity with discounted valuation metrics and solid profitability, though facing competitive pressures from ByteDance's Soda Music. Analyst consensus leans neutral with $12.50 price target representing 49% upside potential. Key risks include user churn among casual listeners and rising operating expenses needed to retain users in the competitive music streaming landscape.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.
Read more on TME →